Neuralink
Neuralink is an Invasive Cortical Implants company founded in 2016 and based in Fremont, United States. It has raised $1.2B in total funding, most recently a Series E in 2025.
Develops high-bandwidth implantable brain-machine interfaces with thousands of electrode channels for paralysis and neurological conditions. Began first human trials in 2024 with the PRIME study, demonstrating cursor control and gaming in paralyzed patients. Raised a $650M Series E in June 2025 at a $9B pre-money valuation, bringing total funding to approximately $1.2B.
The company's first human trials, robot-assisted surgical approach, and massive capital raise have made it the gravitational center of the invasive BCI field.
At a glance
Total raised
$1.2B
Headcount
501-1k
Headquarters
Fremont
United StatesFounded
2016
Status
Private
Subsector
Where Neuralink ranks
Top 25 Brain-Computer Interfaces companies →Funding history
Total raised
$1.2B
Rounds tracked
5
Latest stage
Series E
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Jun 2, 2025 | Series E | $650M | — | ARK Invest, Sequoia Capital, Founders Fund |
| Aug 1, 2023 | Series D | $280M | $5B | Founders Fund |
